HAGLEY SURGERY
1 VICTORIA PASSAGE, HAGLEY, STOURBRIDGE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 7 | 11 | 63.6% | |
| HF 4 | 2011 | 8 | 11 | 72.7% | |
| HF 4 | 2012 | 9 | 14 | 64.3% | |
| HF 4 | 2013 | 8 | 11 | 72.7% | |
| HF004 | 2014 | 3 | 3 | 100.0% | |
| HF004 | 2015 | 1 | 1 | 100.0% | |
| HF004 | 2016 | 2 | 3 | 66.7% | |
| HF004 | 2017 | 34 | 36 | 94.4% | |
| HF004 | 2018 | 38 | 44 | 86.4% | |
| HF004 | 2019 | 46 | 51 | 90.2% | |
| HF004 | 2020 | 62 | 74 | 83.8% | |
| HF006 | 2021 | 84 | 106 | 79.2% | |
| HF006 | 2022 | 83 | 86 | 96.5% | |
| HF006 | 2023 | 84 | 89 | 94.4% |
